New Directions in the Epidemiology of Uterine Fibroids

ABSTRACT

Although uterine leiomyomata (fibroids) have been the leading indication for hysterectomy in the United States for decades, the epidemiological data on fibroid prevalence and risk factors are limited. Given the hormonal dependence of fibroids, most earlier studies focused on reproductive or hormonal factors. Recent analyses have extended that focus to other areas. We present previously unpublished data on the association between reproductive tract infections and fibroids that highlight the need for more detailed studies. Our review suggests that metabolic, dietary, stress, and environmental factors may also play a role in fibroid development.

KEYWORDS

Uterine leiomyoma - epidemiology - reproductive tract infection - sexually transmitted disease - metabolic factors - diet - environment

REFERENCES

• 1 Flake G P, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review.  Environ Health Perspect. 2003;  111(8) 1037-1054
• 2 Stewart E A. Uterine fibroids.  Lancet. 2001;  357(9252) 293-298
• 3 Pokras R, Hufnagel V G. Hysterectomy in the United States, 1965–84.  Am J Public Health. 1988;  78(7) 852-853
• 4 Farquhar C M, Steiner C A. Hysterectomy rates in the United States 1990–1997.  Obstet Gynecol. 2002;  99(2) 229-234
• 5 Flynn M, Jamison M, Datta S, Myers E. Health care resource use for uterine fibroid tumors in the United States.  Am J Obstet Gynecol. 2006;  195(4) 955-964
• 6 Schwartz S M, Marshall L M, Baird D D. Epidemiologic contributions to understanding the etiology of uterine leiomyomata.  Environ Health Perspect. 2000;  108(suppl 5) 821-827
• 7 Payson M, Leppert P, Segars J. Epidemiology of myomas.  Obstet Gynecol Clin North Am. 2006;  33(1) 1-11
• 8 Day Baird D, Dunson D B, Hill M C, Cousins D, Schectman J M. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.  Am J Obstet Gynecol. 2003;  188(1) 100-107
• 9 Bower J K, Schreiner P J, Sternfeld B, Lewis C E. Black-white differences in hysterectomy prevalence: the CARDIA study.  Am J Public Health. 2009;  99(2) 300-307
• 10 Laughlin S K, Baird D D, Savitz D A, Herring A H, Hartmann K E. Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study.  Obstet Gynecol. 2009;  113(3) 630-635
• 11 Borgfeldt C, Andolf E. Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25–40 years.  Acta Obstet Gynecol Scand. 2000;  79(3) 202-207
• 12 Eskenazi B, Warner M, Samuels S et al.. Serum dioxin concentrations and risk of uterine leiomyoma in the Seveso Women's Health Study.  Am J Epidemiol. 2007;  166(1) 79-87
• 13 Luoto R, Kaprio J, Rutanen E M, Taipale P, Perola M, Koskenvuo M. Heritability and risk factors of uterine fibroids—the Finnish Twin Cohort study.  Maturitas. 2000;  37(1) 15-26
• 14 Parazzini F. Risk factors for clinically diagnosed uterine fibroids in women around menopause.  Maturitas. 2006;  55(2) 174-179
• 15 DeWaay D J, Syrop C H, Nygaard I E, Davis W A, Van Voorhis B J. Natural history of uterine polyps and leiomyomata.  Obstet Gynecol. 2002;  100(1) 3-7
• 16 Dixon D, Parrott E C, Segars J H, Olden K, Pinn V W. The second National Institutes of Health International Congress on advances in uterine leiomyoma research: conference summary and future recommendations.  Fertil Steril. 2006;  86(4) 800-806
• 17 Schwartz S M. Epidemiology of uterine leiomyomata.  Clin Obstet Gynecol. 2001;  44(2) 316-326
• 18 Purdie D M, Green A C. Epidemiology of endometrial cancer.  Best Pract Res Clin Obstet Gynaecol. 2001;  15(3) 341-354
• 19 Colditz G A. Epidemiology of breast cancer. Findings from the nurses' health study.  Cancer. 1993;  71(4, suppl) 1480-1489
• 20 Guerrero-Bosagna C M, Sabat P, Valdovinos F S, Valladares L E, Clark S J. Epigenetic and phenotypic changes result from a continuous pre and post natal dietary exposure to phytoestrogens in an experimental population of mice.  BMC Physiol. 2008;  8 17
• 21 Baird D D, Dunson D B. Why is parity protective for uterine fibroids?.  Epidemiology. 2003;  14(2) 247-250
• 22 Wise L A, Palmer J R, Harlow B L et al.. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study.  Am J Epidemiol. 2004;  159(2) 113-123
• 23 Walker C L, Cesen-Cummings K, Houle C, Baird D, Barrett J C, Davis B. Protective effect of pregnancy for development of uterine leiomyoma.  Carcinogenesis. 2001;  22(12) 2049-2052
• 24 Huyck K L, Panhuysen C I, Cuenco K T et al.. The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters.  Am J Obstet Gynecol. 2008;  198(2) 168
• 25 Marshall L M, Spiegelman D, Goldman M B et al.. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata.  Fertil Steril. 1998;  70(3) 432-439
• 26 Lauchlin S K, Herring A H, Savitz D A et al.. Pregnancy-related fibroid reduction.  Fertil Steril. 2010;  , in press
• 27 Peddada S D, Laughlin S K, Miner K et al.. Growth of uterine leiomyomata among premenopausal black and white women.  Proc Natl Acad Sci U S A. 2008;  105(50) 19887-19892
• 28 Burbank F. Childbirth and myoma treatment by uterine artery occlusion: do they share a common biology?.  J Am Assoc Gynecol Laparosc. 2004;  11(2) 138-152
• 29 Wise L A, Palmer J R, Harlow B L et al.. Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the Black Women's Health Study.  Hum Reprod. 2004;  19(8) 1746-1754
• 30 Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhikamraksa N, Werawatakul Y. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study.  Br J Obstet Gynaecol. 1996;  103(9) 909-914
• 31 Lethaby A E, Cooke I, Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.  Cochrane Database Syst Rev. 2005;  (4) , CD002126
• 32 Marshall L M, Spiegelman D, Barbieri R L et al.. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race.  Obstet Gynecol. 1997;  90(6) 967-973
• 33 Chiaffarino F, Parazzini F, La Vecchia C, Chatenoud L, Di Cintio E, Marsico S. Diet and uterine myomas.  Obstet Gynecol. 1999;  94(3) 395-398
• 34 Nagata C, Nakamura K, Oba S, Hayashi M, Takeda N, Yasuda K. Association of intakes of fat, dietary fibre, soya isoflavones and alcohol with uterine fibroids in Japanese women.  Br J Nutr. 2009;  101(10) 1427-1431
• 35 Key J, Hodgson S, Omar R Z et al.. Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues.  Cancer Causes Control. 2006;  17(6) 759-770
• 36 Friberg E, Wolk A. Long-term alcohol consumption and risk of endometrial cancer incidence: a prospective cohort study.  Cancer Epidemiol Biomarkers Prev. 2009;  18(1) 355-358
• 37 Terry K L, De Vivo I, Hankinson S E et al.. Anthropometric characteristics and risk of uterine leiomyoma.  Epidemiology. 2007;  18(6) 758-763
• 38 Marshall L M, Spiegelman D, Manson J E et al.. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking.  Epidemiology. 1998;  9(5) 511-517
• 39 Baird D D, Dunson D B, Hill M C, Cousins D, Schectman J M. Association of physical activity with development of uterine leiomyoma.  Am J Epidemiol. 2007;  165(2) 157-163
• 40 Takeda T, Sakata M, Isobe A et al.. Relationship between metabolic syndrome and uterine leiomyomas: a case-control study.  Gynecol Obstet Invest. 2008;  66(1) 14-17
• 41 Wise L A, Palmer J R, Spiegelman D et al.. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women.  Epidemiology. 2005;  16(3) 346-354
• 42 Azziz R. Reproductive endocrinologic alterations in female asymptomatic obesity.  Fertil Steril. 1989;  52(5) 703-725
• 43 Wegienka G, Baird D D, Hertz-Picciotto I et al.. Self-reported heavy bleeding associated with uterine leiomyomata.  Obstet Gynecol. 2003;  101(3) 431-437
• 44 Hunskaar S. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women.  Neurourol Urodyn. 2008;  27(8) 749-757
• 45 Witherspoon J T, Butler V W. The etiology of uterine fibroids with special reference to the frequency of their occurrence in the Negro: a hypothesis.  Surg Gynecol Obstet. 1934;  58 57-61
• 46 Cohen S. Infection, cell proliferation, and malignancy. In: Parsonnet J Microbes and Malignancy Infection as a Cause of Human Cancers. New York, NY; Oxford University Press 1999: 89-106
• 47 McClain K L, Leach C T, Jenson H B et al.. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS.  N Engl J Med. 1995;  332(1) 12-18
• 48 Stewart E A, Nowak R A. New concepts in the treatment of uterine leiomyomas.  Obstet Gynecol. 1998;  92(4 Pt 1) 624-627
• 49 Leppert P C, Catherino W H, Segars J H. A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays.  Am J Obstet Gynecol. 2006;  195(2) 415-420
• 50 Cramer S F, Mann L, Calianese E, Daley J, Williamson K. Association of seedling myomas with myometrial hyperplasia.  Hum Pathol. 2009;  40(2) 218-225
• 51 Rogers R, Norian J, Malik M et al.. Mechanical homeostasis is altered in uterine leiomyoma.  Am J Obstet Gynecol. 2008;  198(4) 474
• 52 Catherino W, Salama A, Potlog-Nahari C, Leppert P, Tsibris J, Segars J. Gene expression studies in leiomyomata: new directions for research.  Semin Reprod Med. 2004;  22(2) 83-90
• 53 Cramer S F, Padela A I, Marchetti C E, Newcomb P M, Heller D S. Myometrial hyperplasia in pediatric, adolescent, and young adult uteri.  J Pediatr Adolesc Gynecol. 2003;  16(5) 301-306
• 54 Finn O J. Cancer immunology.  N Engl J Med. 2008;  358(25) 2704-2715
• 55 Murta E F, Oliveira G P, Prado FdeO, De Souza M A, Tavares Murta B M, Adad S J. Association of uterine leiomyoma and Chagas' disease.  Am J Trop Med Hyg. 2002;  66(3) 321-324
• 56 Faerstein E, Szklo M, Rosenshein N B. Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation.  Am J Epidemiol. 2001;  153(1) 11-19
• 57 zur Hausen H. Papillomavirus infections—a major cause of human cancers.  Biochim Biophys Acta. 1996;  1288(2) F55-F78
• 58 Lopez-Borges S, Gallego M I, Lazo P A. Recurrent integration of papillomavirus DNA within the human 12q14-15 uterine breakpoint region in genital carcinomas.  Genes Chromosomes Cancer. 1998;  23(1) 55-60
• 59 Wei J J, Chiriboga L, Mittal K. Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata.  Fertil Steril. 2005;  84(2) 474-484
• 60 Klemke M, Meyer A, Nezhad M H et al.. Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease.  Genes Chromosomes Cancer. 2009;  48(2) 171-178
• 61 Baird D D, Kesner J S, Dunson D B. Luteinizing hormone in premenopausal women may stimulate uterine leiomyomata development.  J Soc Gynecol Investig. 2006;  13(2) 130-135
• 62 Cramer S F, Robertson Jr A L, Ziats N P, Pearson O H. Growth potential of human uterine leiomyomas: some in vitro observations and their implications.  Obstet Gynecol. 1985;  66(1) 36-41
• 63 Baird D D, Travlos G, Wilson R et al.. Uterine leiomyomata in relation to insulin-like growth factor-I, insulin, and diabetes.  Epidemiology. 2009;  20(4) 604-610
• 64 Wise L A, Palmer J R, Stewart E A, Rosenberg L. Polycystic ovary syndrome and risk of uterine leiomyomata.  Fertil Steril. 2007;  87(5) 1108-1115
• 65 Walocha J A, Litwin J A, Miodoński A J. Vascular system of intramural leiomyomata revealed by corrosion casting and scanning electron microscopy.  Hum Reprod. 2003;  18(5) 1088-1093
• 66 Boynton-Jarrett R, Rich-Edwards J, Malspeis S, Missmer S A, Wright R. A prospective study of hypertension and risk of uterine leiomyomata.  Am J Epidemiol. 2005;  161(7) 628-638
• 67 Silver M A, Raghuvir R, Fedirko B, Elser D. Systemic hypertension among women with uterine leiomyomata: potential final common pathways of target end-organ remodeling.  J Clin Hypertens (Greenwich). 2005;  7(11) 664-668
• 68 Settnes A, Andreasen A H, Jørgensen T. Hypertension is associated with an increased risk for hysterectomy: a Danish cohort study.  Eur J Obstet Gynecol Reprod Biol. 2005;  122(2) 218-224
• 69 Isobe A, Takeda T, Sakata M et al.. Dual repressive effect of angiotensin II- type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation.  Hum Reprod. 2008;  23(2) 440-446
• 70 Divisi D, Di Tommaso S, Salvemini S, Garramone M, Crisci R. Diet and cancer.  Acta Biomed. 2006;  77(2) 118-123
• 71 Atkinson C, Lampe J W, Scholes D, Chen C, Wähälä K, Schwartz S M. Lignan and isoflavone excretion in relation to uterine fibroids: a case-control study of young to middle-aged women in the United States.  Am J Clin Nutr. 2006;  84(3) 587-593
• 72 Terry K L, Missmer S A, Hankinson S E, Willett W C, De Vivo I. Lycopene and other carotenoid intake in relation to risk of uterine leiomyomata.  Am J Obstet Gynecol. 2008;  198(1) 37.e1-8
• 73 Antoni M H, Lutgendorf S K, Cole S W et al.. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms.  Nat Rev Cancer. 2006;  6(3) 240-248
• 74 Godbout J P, Glaser R. Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer.  J Neuroimmune Pharmacol. 2006;  1(4) 421-427
• 75 Lupien S J, McEwen B S, Gunnar M R, Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition.  Nat Rev Neurosci. 2009;  10(6) 434-445
• 76 Figueredo V M. The time has come for physicians to take notice: the impact of psychosocial stressors on the heart.  Am J Med. 2009;  122(8) 704-712
• 77 Wise L A, Palmer J R, Cozier Y C et al.. Perceived racial discrimination and risk of uterine leiomyomata.  Epidemiology. 2007;  18(6) 747-757
• 78 Wirth M M, Meier E A, Fredrickson B L, Schultheiss O C. Relationship between salivary cortisol and progesterone levels in humans.  Biol Psychol. 2007;  74(1) 104-107
• 79 Newbold R. Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens.  Environ Health Perspect. 1995;  103(suppl 7) 83-87
• 80 Newbold R R, Moore A B, Dixon D. Characterization of uterine leiomyomas in CD-1 mice following developmental exposure to diethylstilbestrol (DES).  Toxicol Pathol. 2002;  30(5) 611-616
• 81 Greathouse K L, Cook J D, Lin K et al.. Identification of uterine leiomyoma genes developmentally reprogrammed by neonatal exposure to diethylstilbestrol.  Reprod Sci. 2008;  15(8) 765-778
• 82 Baird D D, Newbold R. Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development.  Reprod Toxicol. 2005;  20(1) 81-84
• 83 Wise L A, Palmer J R, Rowlings K et al.. Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure.  Obstet Gynecol. 2005;  105(1) 167-173
• 84 Gomez-Duran A, Carvajal-Gonzalez J M, Mulero-Navarro S, Santiago-Josefat B, Puga A, Fernandez-Salguero P M. Fitting a xenobiotic receptor into cell homeostasis: how the dioxin receptor interacts with TGFbeta signaling.  Biochem Pharmacol. 2009;  77(4) 700-712
• 85 Pevenstein S R, Williams R K, McChesney D, Mont E K, Smialek J E, Straus S E. Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia.  J Virol. 1999;  73(12) 10514-10518
• 86 Zerr D M, Gooley T A, Yeung L et al.. Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients.  Clin Infect Dis. 2001;  33(6) 763-771
• 87 Zerr D M, Huang M L, Corey L, Erickson M, Parker H L, Frenkel L M. Sensitive method for detection of human herpesviruses 6 and 7 in saliva collected in field studies.  J Clin Microbiol. 2000;  38(5) 1981-1983
• 88 Lallemand F, Desire N, Rozenbaum W, Nicolas J C, Marechal V. Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay.  J Clin Microbiol. 2000;  38(4) 1404-1408